Services
Commercial Growth & Go-to-Market Execution
If growth is flat or your product or service is underperforming, CGP can help you understand why and make corrections.
CGP can help you evaluate and create:
-
Market segmentation and ICP definition (biotech vs biopharma, R&D vs production)
-
Territory and channel strategy (direct vs dealer vs hybrid)
-
Sales force structure, quotas, and compensation logic
-
Strategy for top 10–25 accounts
-
Pricing discipline and discount control
-
Product analysis (competition, life cycle)
Interim / Fractional Commercial Leadership
If you are in the early stages of company foundation or need guidance in structure, all with defined scope and duration, CGP can offer:
-
Fractional CRO services
-
Interim VP Sales / Marketing
-
Interim CEO
What this includes:
-
Weekly operating cadence
-
Pipeline ownership and forecasting
-
Sales manager coaching
-
Board-level reporting and decision support
North American Market Entry & Expansion
If you are looking to enter the US life science market with a product or service,
CGP can create:
-
U.S. market readiness assessment
-
Pricing and channel adaptation
-
Service and support model design
-
First 10-customer acquisition plan
C-Suite or Board-level Advisory
Credible leadership and advice is in short supply. CGP can help.
-
Monthly or biweekly advisory calls
-
Decision framing, risk tradeoffs, execution sequencing
-
Confidential, operator-to-operator support
-
Transition advisory
-
Restructuring or turnaround planning
Driving Cultural Impact
25+
Years of Experience in the bioprocess community
10+
Executive leadership experience
9
50
9 figures in sales and service revenue
Sales in every state
About Andy
Andrew Magno is a senior life-sciences executive known for combining technical credibility, integrity, and hands-on leadership with disciplined execution. With more than two decades in the biotechnology and biopharmaceutical equipment sector, he has a track record of turning strategy into measurable results.
From research to production, Andy brings deep expertise in upstream bioprocess, including both incubator shakers and bioreactors. He applies real-world experience to product development, market strategy, commercialization and leadership. Andy has personally driven and led teams responsible for hundreds of millions of dollars in sales and played a key role in building the North American market for a leading European manufacturer of premium shakers and bioreactors. Today, he works closely with leadership teams and investors to help shape companies through active involvement, strong execution, and leadership by example.
25+
GET IN TOUCH
Let's define a direction
Let us help you define your mission and secure your vision. Reach out to us to find out more.
